Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus

Diabetic Medicine

Volumn 14, Issue 5, 1997, Pages 376-380

  Mohamed Ali, V ^a   Pinkney, J H ^a,b   Panahloo, A ^a,c   Goodrick, S ^a   Coppack, S W ^a   Yudkin, J S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

insulin; insulin resistance; leptin; non insulin dependent diabetes mellitus; obesity

Indexed keywords

LEPTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNORADIOMETRIC ASSAY; INSULIN; INSULIN RESISTANCE; LEPTIN; METABOLIC CLEARANCE RATE; MIDDLE AGED; OBESITY; PROTEINS; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 0030996549     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199705)14:5<376::AID-DIA370>3.0.CO;2-9     Document Type: Article

References (21)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
3. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45: 984-987.
4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
5. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1: 1157-1161.
6. MacDougald OA, Hwang C, Fan H, Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Nat Acad Sci 1995; 92: 9034-9037.
7. Trayhurn P, Duncan JS, Rayner DV. Acute cold-induced suppression of oh (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 1995; 311: 729-733.
8. Zimmet P, Alberti KGMM. Leptin: is it important in diabetes? Diabetic Med 1996; 13: 504-509.
9. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701.
10. Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, Abe H. Glucose insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab 1977; 45: 1124-1127.
11. Heine RJ, Home PD, Poncher M, Orskov H, Hammond V, McCulloch AJ, et al. A comparison of 3 methods of assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance. Diabetes Res 1985; 2: 113-120.
12. Nagi DK, Yudkin JS. The reproducibility of the insulin test (IST) without pancreatic suppression (modified Harano technique) as an index of insulin resistance in non-insulin-dependent diabetic subjects. Diabetic Med 1990; 7 (suppl 2): P19.
13. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects-evidence against a modulating role for insulin. Diabetologia 1995; 38: 1110-1116.
14. Goodrick S, Mohamed-Ali V, Jowett T, O'Shea A, Yudkin JS, Coppack SW. A two-site, monoclonal, immunoradiometric assay for human leptin. Diabetologia 1996; 39: PS17 (A142).
15. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996; 45: 822-824.
16. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, et al. Serum leptin concentrations, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 1996; 313: 965-969.
17. Malmström R, Taskinen MR, Karonen SL, Yki-Järvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
18. Mohamed-Ali V, Goodrick SJ, Stanner SA, Rawesh A, Yudkin JS, Coppack SW. Adipose tissue leptin production at fasting and after a high carbohydrate meal. Diabetic Med 1996; 13: A10.
19. Lindstrom T, Eriksson P, Olsson AG, Arnqvist HJ. Long-term improvement of glycaemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care 1995; 17: 719-721.
20. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, et al. Evidence of free and bound leptin in human circulation. J Clin Invest 1996; 98: 1277-1282.
21. Schwartz MW, Peskind E, Paskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 1996; 2: 589-593.